• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ALT
Click for more information
0.00% 0.5¢

ANALYTICA LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Analytica Limited is engaged in the design, development and supply of Class I and II... Analytica Limited is engaged in the design, development and supply of Class I and II medical devices. The Company's segments include Medical devices and Corporate. The Medical devices segment's products include PeriCoach (Perineometer), ELF-2 and AutoStart burette. The Company's lead product is the PeriCoach System, an e-health treatment system for women suffering from stress urinary incontinence. PeriCoach includes a device, Web portal and smartphone application. The device evaluates activity in pelvic floor muscles. The information is transmitted to a smartphone application and can be loaded to PeriCloud where physicians can monitor patient progress through Web portal. The Analytica Autostart Infusion System offers solution to regular monitoring and refilling of burettes in intravenous fluid infusion. The Autostart burette contains a float system that automatically restarts intra-venous (IV) fluid flow following infused delivery of the predetermined amount of a required medication.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
ALT Pericoach App for Apple IOS released12/01/15
ALT Change of Director's Interest Notice19/12/14
ALT Change of Director's Interest Notice18/12/14
ALT PeriCoach Update17/12/14
ALT Results of Meeting28/11/14
ALT Shareholder video27/11/14
ALT CEO presentation27/11/14
ALT Chairman's Address to Shareholders27/11/14
ALT Pericoach system consumer release24/11/14
ALT Pericoach Release UpdatePRICE SENSITIVE13/11/14
ALT Change of Director's Interest Notices11/11/14
ALT Notice under Sec 708A of Corporations Act07/11/14
ALT Appointment Global Public Relations Agency07/11/14
ALT Appendix 3B06/11/14
ALT Appendix 4C - quarterlyPRICE SENSITIVE31/10/14
ALT Funds received - Entitlement offer31/10/14
ALT Pericoach Clinical Trial preparationPRICE SENSITIVE29/10/14
ALT Notice of Annual General Meeting/Proxy Form24/10/14
ALT Receipt of R and D tax redate $989kPRICE SENSITIVE24/10/14
ALT entitlement offer - documents despatched17/10/14
ALT Shareholder Information evening presentations14/10/14
ALT MOU signed with Sportsmed GlobalPRICE SENSITIVE13/10/14
ALT CE Mark approval granted for PeriCoachPRICE SENSITIVE09/10/14
ALT Section 708A Notice and appendix 3B for placement08/10/14
ALT Section 708AA Notice08/10/14
ALT Letter to option holders08/10/14
ALT Letter to ineligible shareholders08/10/14
ALT Letter to eligible shareholders08/10/14
ALT Entitlement offer and investor presentationPRICE SENSITIVE08/10/14
ALT Reinstatement to Official QuotationPRICE SENSITIVE03/10/14
ALT Appendix 3B03/10/14
ALT Capital RaisingPRICE SENSITIVE03/10/14
ALT Extension Voluntary Suspension02/10/14
ALT Suspension from Official QuotationPRICE SENSITIVE30/09/14
ALT Trading HaltPRICE SENSITIVE29/09/14
ALT Annual Report to shareholders26/09/14
ALT Patersons Securities research report update19/09/14
ALT PeriCoach Marketing UpdatePRICE SENSITIVE17/09/14
ALT Change of Director's Interest Notice09/09/14
ALT September Newsletter04/09/14
ALT Appendix 4E - Preliminary Final ReportPRICE SENSITIVE29/08/14
ALT Clinical Advisory Boards - Australia and USA19/08/14
ALT Appendix 4C - quarterlyPRICE SENSITIVE31/07/14
ALT Pericoach Controlled Market Release UpdatePRICE SENSITIVE02/07/14
ALT Change in substantial holding04/06/14
ALT Patersons Securities Research Report - coverage commences02/06/14
ALT Pericoarch production commencedPRICE SENSITIVE29/05/14
ALT Change of Director's Interest Notice28/05/14
ALT PeriCoach app released on google store27/05/14
ALT PeriCoach UpdatePRICE SENSITIVE23/05/14
ALT Appendix 3B - amended22/05/14
ALT Appendix 3B22/05/14
ALT Entitlement offer subsciption result20/05/14
ALT Change of Director's Interest Notice09/05/14
ALT Reimbursement of Uninary Incontinence Health Costs07/05/14
ALT Entitlement Offer documents06/05/14
ALT Appendix 4C - quarterlyPRICE SENSITIVE30/04/14
ALT Letter to eligible shareholders - entitlement offer24/04/14
ALT Letter to Ineligible shareholders - entitlement offer24/04/14
ALT Letter to Option holders- entitlement offer24/04/14
ALT Section 708A notice - entitlement offer24/04/14
ALT Appendix 3B - Entitlement offer24/04/14
ALT Entitlement OfferPRICE SENSITIVE24/04/14
ALT S708A notice and appendix 3B23/04/14
ALT Capital RaisingPRICE SENSITIVE22/04/14
ALT Trading HaltPRICE SENSITIVE16/04/14
ALT Shareholders update08/04/14
ALT PeriCoach Marketing Update01/04/14
ALT Change of Director's Interest Notice31/03/14
ALT Product Development UpdatePRICE SENSITIVE31/03/14
ALT Change of Director's Interest Notice18/03/14
ALT CFO appointment12/03/14
ALT Appendix 4D and Half Year financial reportPRICE SENSITIVE28/02/14
ALT Updated investor presentation14/02/14
ALT Appendix 3B12/02/14
ALT CEO appointmentPRICE SENSITIVE12/02/14
ALT Appendix 4C - quarterlyPRICE SENSITIVE31/01/14
ALT Initial Director's Interest Notice13/01/14
ALT Appointment of director13/01/14
ALT December 2013 Shareholder update19/12/13
ALT Investor presentation26/11/13
ALT Section 708A Notice15/11/13
ALT Change in substantial holding13/11/13
ALT Ceasing to be a substantial holder13/11/13
ALT Change of Director's Interest Notice13/11/13
ALT TGA registration received from TGA for PeriCoach SystemPRICE SENSITIVE13/11/13
ALT Appendix 3B11/11/13
ALT Successful $2.2m fund raising completed08/11/13
ALT Appendix 4C - quarterlyPRICE SENSITIVE31/10/13
ALT Results of AGM31/10/13
ALT Presentation to AGM30/10/13
ALT Chairmans Address at AGM30/10/13
ALT Investment presentation to Perth brokers24/10/13
ALT R and D tax incentive refund received - $514kPRICE SENSITIVE24/10/13
ALT First PeriCoach ProductionPRICE SENSITIVE22/10/13
ALT Pericoach Clinical Advisory Board formed09/10/13
ALT Notice of Annual General Meeting/Proxy Form30/09/13
ALT Shareholders Newsletter30/09/13
ALT Chairmans letter SPP30/09/13
ALT Share Purchase Plan documents30/09/13
ALT Pericoach App for Apple IOS released
12/01/15
ALT Change of Director's Interest Notice
19/12/14
ALT Change of Director's Interest Notice
18/12/14
ALT PeriCoach Update
17/12/14
ALT Results of Meeting
28/11/14
ALT Shareholder video
27/11/14
ALT CEO presentation
27/11/14
ALT Chairman's Address to Shareholders
27/11/14
ALT Pericoach system consumer release
24/11/14
ALT Pericoach Release Update
13/11/14PRICE SENSITIVE
ALT Change of Director's Interest Notices
11/11/14
ALT Notice under Sec 708A of Corporations Act
07/11/14
ALT Appointment Global Public Relations Agency
07/11/14
ALT Appendix 3B
06/11/14
ALT Appendix 4C - quarterly
31/10/14PRICE SENSITIVE
ALT Funds received - Entitlement offer
31/10/14
ALT Pericoach Clinical Trial preparation
29/10/14PRICE SENSITIVE
ALT Notice of Annual General Meeting/Proxy Form
24/10/14
ALT Receipt of R and D tax redate $989k
24/10/14PRICE SENSITIVE
ALT entitlement offer - documents despatched
17/10/14
ALT Shareholder Information evening presentations
14/10/14
ALT MOU signed with Sportsmed Global
13/10/14PRICE SENSITIVE
ALT CE Mark approval granted for PeriCoach
09/10/14PRICE SENSITIVE
ALT Section 708A Notice and appendix 3B for placement
08/10/14
ALT Section 708AA Notice
08/10/14
ALT Letter to option holders
08/10/14
ALT Letter to ineligible shareholders
08/10/14
ALT Letter to eligible shareholders
08/10/14
ALT Entitlement offer and investor presentation
08/10/14PRICE SENSITIVE
ALT Reinstatement to Official Quotation
03/10/14PRICE SENSITIVE
ALT Appendix 3B
03/10/14
ALT Capital Raising
03/10/14PRICE SENSITIVE
ALT Extension Voluntary Suspension
02/10/14
ALT Suspension from Official Quotation
30/09/14PRICE SENSITIVE
ALT Trading Halt
29/09/14PRICE SENSITIVE
ALT Annual Report to shareholders
26/09/14
ALT Patersons Securities research report update
19/09/14
ALT PeriCoach Marketing Update
17/09/14PRICE SENSITIVE
ALT Change of Director's Interest Notice
09/09/14
ALT September Newsletter
04/09/14
ALT Appendix 4E - Preliminary Final Report
29/08/14PRICE SENSITIVE
ALT Clinical Advisory Boards - Australia and USA
19/08/14
ALT Appendix 4C - quarterly
31/07/14PRICE SENSITIVE
ALT Pericoach Controlled Market Release Update
02/07/14PRICE SENSITIVE
ALT Change in substantial holding
04/06/14
ALT Patersons Securities Research Report - coverage commences
02/06/14
ALT Pericoarch production commenced
29/05/14PRICE SENSITIVE
ALT Change of Director's Interest Notice
28/05/14
ALT PeriCoach app released on google store
27/05/14
ALT PeriCoach Update
23/05/14PRICE SENSITIVE
ALT Appendix 3B - amended
22/05/14
ALT Appendix 3B
22/05/14
ALT Entitlement offer subsciption result
20/05/14
ALT Change of Director's Interest Notice
09/05/14
ALT Reimbursement of Uninary Incontinence Health Costs
07/05/14
ALT Entitlement Offer documents
06/05/14
ALT Appendix 4C - quarterly
30/04/14PRICE SENSITIVE
ALT Letter to eligible shareholders - entitlement offer
24/04/14
ALT Letter to Ineligible shareholders - entitlement offer
24/04/14
ALT Letter to Option holders- entitlement offer
24/04/14
ALT Section 708A notice - entitlement offer
24/04/14
ALT Appendix 3B - Entitlement offer
24/04/14
ALT Entitlement Offer
24/04/14PRICE SENSITIVE
ALT S708A notice and appendix 3B
23/04/14
ALT Capital Raising
22/04/14PRICE SENSITIVE
ALT Trading Halt
16/04/14PRICE SENSITIVE
ALT Shareholders update
08/04/14
ALT PeriCoach Marketing Update
01/04/14
ALT Change of Director's Interest Notice
31/03/14
ALT Product Development Update
31/03/14PRICE SENSITIVE
ALT Change of Director's Interest Notice
18/03/14
ALT CFO appointment
12/03/14
ALT Appendix 4D and Half Year financial report
28/02/14PRICE SENSITIVE
ALT Updated investor presentation
14/02/14
ALT Appendix 3B
12/02/14
ALT CEO appointment
12/02/14PRICE SENSITIVE
ALT Appendix 4C - quarterly
31/01/14PRICE SENSITIVE
ALT Initial Director's Interest Notice
13/01/14
ALT Appointment of director
13/01/14
ALT December 2013 Shareholder update
19/12/13
ALT Investor presentation
26/11/13
ALT Section 708A Notice
15/11/13
ALT Change in substantial holding
13/11/13
ALT Ceasing to be a substantial holder
13/11/13
ALT Change of Director's Interest Notice
13/11/13
ALT TGA registration received from TGA for PeriCoach System
13/11/13PRICE SENSITIVE
ALT Appendix 3B
11/11/13
ALT Successful $2.2m fund raising completed
08/11/13
ALT Appendix 4C - quarterly
31/10/13PRICE SENSITIVE
ALT Results of AGM
31/10/13
ALT Presentation to AGM
30/10/13
ALT Chairmans Address at AGM
30/10/13
ALT Investment presentation to Perth brokers
24/10/13
ALT R and D tax incentive refund received - $514k
24/10/13PRICE SENSITIVE
ALT First PeriCoach Production
22/10/13PRICE SENSITIVE
ALT Pericoach Clinical Advisory Board formed
09/10/13
ALT Notice of Annual General Meeting/Proxy Form
30/09/13
ALT Shareholders Newsletter
30/09/13
ALT Chairmans letter SPP
30/09/13
ALT Share Purchase Plan documents
30/09/13
refresh Created with Sketch. REFRESH
 

Top Stories

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
Tambourah chases gold veins and mineralisation extension with drilling Tambourah Metals Ltd has discovered two high-grade gold veins through a diamond drilling program in Western Australia
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.